BLENREP REMS

blenreprems.com

The BLENREP Risk Evaluation and Mitigation Strategy (REMS) is a restricted program mandated by GSK to mitigate the risk of ocular toxicity associated with the prescription medication BLENREP. The platform facilitates certification for prescribers, healthcare settings, and patient enrollment to ensure compliance with required ophthalmic monitoring protocols. It serves as the central hub for accessing prescribing information, educational resources, and adverse reaction reporting tools.

LLM mention score The LLM mention score is the total number of mentions of this brand in different LLM chatbots, normalized to the scale from 0 to 100. You can get actual, non-normalized numbers via the LLM Mention API from DataForSEO.

Normalized 0–100 · last 8 weeks

DataForSEO API

Get LLM mention data of any company via DataForSEO API

Get access to the structured data on keyword, brand, and website mentions in LLMs, including metrics like AI search volume, impressions, and mentions count. 

How to get LLM mention data →
// Fetch BLENREP REMS mentions
POST v3/ai_optimization/llm_mentions/search/live
[
    {
        "target": [
            {
                "keyword": "BLENREP REMS",
                "search_scope": ["any"]
            }
        ],
        "platform": "chat_gpt",
        "order_by" : ["ai_search_volume,desc"]
    }
]